Welcome to LookChem.com Sign In|Join Free

CAS

  • or
methyl (2Z,4E,6Z,8Z)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)no na-2,4,6,8-tetraenoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

16760-45-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 16760-45-5 Structure
  • Basic information

    1. Product Name: methyl (2Z,4E,6Z,8Z)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)no na-2,4,6,8-tetraenoate
    2. Synonyms: methyl (2Z,4E,6Z,8Z)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)no na-2,4,6,8-tetraenoate
    3. CAS NO:16760-45-5
    4. Molecular Formula: C21H30O2
    5. Molecular Weight: 314.46
    6. EINECS: N/A
    7. Product Categories: Retinoids
    8. Mol File: 16760-45-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 426.1°Cat760mmHg
    3. Flash Point: 229.8°C
    4. Appearance: /
    5. Density: 0.975g/cm3
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.535
    8. Storage Temp.: Amber Vial, -86°C Freezer
    9. Solubility: N/A
    10. Stability: At 00C.
    11. CAS DataBase Reference: methyl (2Z,4E,6Z,8Z)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)no na-2,4,6,8-tetraenoate(CAS DataBase Reference)
    12. NIST Chemistry Reference: methyl (2Z,4E,6Z,8Z)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)no na-2,4,6,8-tetraenoate(16760-45-5)
    13. EPA Substance Registry System: methyl (2Z,4E,6Z,8Z)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)no na-2,4,6,8-tetraenoate(16760-45-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 16760-45-5(Hazardous Substances Data)

16760-45-5 Usage

Chemical Properties

Light Yellow Oil

Uses

Retinoic acid derivative.

Check Digit Verification of cas no

The CAS Registry Mumber 16760-45-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,7,6 and 0 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 16760-45:
(7*1)+(6*6)+(5*7)+(4*6)+(3*0)+(2*4)+(1*5)=115
115 % 10 = 5
So 16760-45-5 is a valid CAS Registry Number.
InChI:InChI=1/C21H30O2/c1-16(9-7-10-17(2)15-20(22)23-6)12-13-19-18(3)11-8-14-21(19,4)5/h7,9-10,12-13,15H,8,11,14H2,1-6H3/b10-7+,13-12+,16-9+,17-15-

16760-45-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 13-cis Retinoic Acid Methyl Ester

1.2 Other means of identification

Product number -
Other names 9-cis-Retinoic Acid Methyl Ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16760-45-5 SDS

16760-45-5Relevant articles and documents

Assignment of 1H and 13C NMR Spectra of Retinoic Acid Ester Isomers Observed in the Long-Wavelength UV-Induced Photostationary State

Curley, Robert W.,Fowble, John W.

, p. 707 - 709 (1989)

1H and 13C chemical shift assignments, obtained with the aid of two-dimensional hetenuclear shift correlation and double-quantum coherence 13C-INADEQUATE experiments, are reported for four retinoic acid ester isomers observed at the photostationary state.Also detailed are 1H assignments for three additional isomers obtained in insufficient amounts for 13C measurements.KEY WORDS - Retionic acid esters Isomer identification 1H-13C correlation spectra 13C-INADEQUATE experiment

AN IMPROVED PROCESS FOR THE PREPARATION OF 4-OXOISOTRETINOIN

-

Page/Page column 12, (2022/02/28)

The present invention relates to an improved process for the preparation of 4-Oxoisotretinoin and purification process of 4-Oxoisotretinoin (I) and crystalline 5 form of 4-Oxoisotretinoin (I).

13-CIS-RAMBA RETINAMIDES THAT DEGRADE MNKS FOR TREATING CANCER

-

Page/Page column 52, (2016/06/20)

The synthesis and in vitro and in vivo anti-breast and anti-prostate cancers activities of novel C-4 heteroaryl 13-cis retinamides that modulate Mnk-eIF4E and AR signaling are discussed. In both breast and prostate cancer cell lines, these compounds induc

Novel C-4 heteroaryl 13- cis -retinamide Mnk/AR degrading agents inhibit cell proliferation and migration and induce apoptosis in human breast and prostate cancer cells and suppress growth of MDA-MB-231 human breast and CWR22Rv1 human prostate tumor xenografts in mice

Mbatia, Hannah W.,Ramalingam, Senthilmurugan,Ramamurthy, Vidya P.,Martin, Marlena S.,Kwegyir-Afful, Andrew K.,Njar, Vincent C. O.

, p. 1900 - 1914 (2015/04/27)

The synthesis and in vitro and in vivo antibreast and antiprostate cancers activities of novel C-4 heteroaryl 13-cis-retinamides that modulate Mnk-eIF4E and AR signaling are discussed. Modifications of the C-4 heteroaryl substituents reveal that the 1H-imidazole is essential for high anticancer activity. The most potent compounds against a variety of human breast and prostate cancer (BC/PC) cell lines were compounds 16 (VNHM-1-66), 20 (VNHM-1-81), and 22 (VNHM-1-73). In these cell lines, the compounds induce Mnk1/2 degradation to substantially suppress eIF4E phosphorylation. In PC cells, the compounds induce degradation of both full-length androgen receptor (fAR) and splice variant AR (AR-V7) to inhibit AR transcriptional activity. More importantly, VNHM-1-81 has strong in vivo antibreast and antiprostate cancer activities, while VNHM-1-73 exhibited strong in vivo antibreast cancer activity, with no apparent host toxicity. Clearly, these lead compounds are strong candidates for development for the treatments of human breast and prostate cancers.

Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice

Patel, Jyoti B.,Huynh, Carlic K.,Handratta, Venkatesh D.,Gediya, Lalji K.,Brodie, Angela M. H.,Goloubeva, Olga G.,Clement, Omoshile O.,Nanne, Ivo P.,Soprano, Dianne Robert,Njar, Vincent C. O.

, p. 6716 - 6729 (2007/10/03)

Novel retinoic acid metabolism blocking agents (RAMBAs) have been synthesized and characterized. The synthetic features include introduction of nucleophilic ligands at C-4 of all-trans-retinoic acid (ATRA) and 13-cis-retinoic acid, and modification of ter

Reactivity of retinoids and carotenoids in autoxidation

Finkelshtein,Krasnokutskaya

, p. 411 - 418 (2007/10/03)

The autoxidation of various retinyl polyenes and carotenoids in chlorobenzene at 45 °C and in thin solid films on a support at room temperature was investigated. The compounds used were β-carotene, canthaxanthin, retinyl acetate, methyl (all-E)-retinoate, methyl (13Z)-retinoate, retinal, C18 ketone, β-ionylidene acetaldehyde, ψionone, β-ionone and ethyl sorbate as a model compound. It was shown that the isomerization of polyenyl peroxy radicals occurs during autoxidation of all the compounds studied, excepting β-ionone. A kinetic scheme for the polyene autoxidation process was considered and analysed. The conditions under which the rate constants of elementary reactions may be determined were defined and the rate constants of propagation and termination reactions for different polyenes were evaluated. The disappearance and formation of different functional groups were monitored by the spectroscopic investigation of autoxidation of polyene solid films. Mechanisms of the initial stages of the process are proposed for different polyenes.

Low-valent titanium reductive elimination: a direct and highly stereoselective synthesis of vitamin A aldehyde and all-trans retinoic acid orthothioester

Solladie, G.,Berl, V.

, p. 568 - 574 (2007/10/02)

It is shown that low-valent titanium reductive elimination can be carried out in the presence of a thioacetal or an orthothioester group.The application to the synthesis of vitamin A aldehyde and all-trans retinoic acid orthothioester is described.Keywords - Ti(0) reductive elimination / vitamin A aldehyde / all-trans retinoic acid

SYNTHETIC INVESTIGATIONS IN THE CHEMISTRY OF POLYENE COMPOUNDS LII. SYNTHESIS OF RETINOIC AND DIHYDRORETINOIC ESTERS BY THE REFORMATSKII REACTION

Tutorskaya, O. O.,Miropol'skaya, M. A.,Samokhvalov, G. I.

, p. 1237 - 1240 (2007/10/02)

The esters of 7,8- and 7,14-dihydroretinoic acids were obtained by the reaction of 6-methyl-8-(2,6,6-trimethyl-1-cyclohexenyl)-3,5-octadien-2-one with bromoacetic ester in the Reformatskii reaction followed by dehydration.The 7,8- and 7,14-dihydroretinoic

NEW MASKED BUILDING BLOCK FOR ISOPRENOID POLYENE CHAIN SYNTHESIS

Mandai, T.,Iuchi, Y.,Suzuki, K.,Kawada, M.,Otera, J.

, p. 4721 - 4724 (2007/10/02)

The new building blocks 2, 3, and 4 have been effectively synthesized starting from 2-hydroxymethyl-4-phenylthio-1-butene (1a).A convenient synthesis of retinoic acid methyl ester (9) using 2 is also described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16760-45-5